AtCor Medical Holdings Limited announced that it has entered into a multi-year supply agreement with PhysioAge Systems, LLC. Participating practices will now be able to offer noninvasive arterial stiffness measurements, as provided by SphygmoCor, one of the important biomarkers of physiological age. Arterial stiffness has become a critical biomarker in aging and a key driver of the risk for hypertension and cardiovascular disease. The two year agreement will streamline the integration of SphygmoCor into the PhysioAge Program, making it more accessible to participating practices. Up to 100 new PhysioAge sites are forecast to install AtCor's SphygmoCor in calendar year 2018 - with eleven units sold in December 2017.